Prescription drug · NDA
Lyrica (Pregabalin) NDC 0071-1018
Pregabalin 300 mg/1 · Capsule · Oral · Parke-Davis Div of Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0071-1018-68 | 00071101868 | 90 CAPSULE in 1 BOTTLE (0071-1018-68)Marketed from Dec 30, 2004 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lyrica
- Generic name (nonproprietary)
- pregabalin
- Active ingredients
- Pregabalin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Parke-Davis Div of Pfizer IncNDC labeler code 0071
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021446
- Marketing start
- Marketing end
- DEA schedule
- CV
- Identifiers
- Product ID 0071-1018_e7c79058-03ba-4e7f-9a31-9ec5ce245161SPL ID e7c79058-03ba-4e7f-9a31-9ec5ce245161SPL set ID 60185c88-ecfd-46f9-adb9-b97c6b00a553RxCUI 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127, 607018, 607020, 607022, 607024, 607026, 607028, 607033, 607038, 898715, 898718UNII 55JG375S6MUPC 0300711012683
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400071101868followed by a unit qualifier and the quantityPackage 00071-1018-68. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LYRICA is indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury LYRICA is indicated for: • Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) • Postherpetic neuralgia (PHN) ( 1 ) • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) • Fibromyalgia ( 1 ) • Neuropathic pain associated with spinal cord injury ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0071-1018
- What is NDC 0071-1018?
- 0071-1018 is the product NDC for Lyrica (pregabalin), Pregabalin 300 mg/1 capsule, listed with the FDA by Parke-Davis Div of Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lyrica (Pregabalin).
- What is the active ingredient?
- Pregabalin.
- Who is the labeler?
- Parke-Davis Div of Pfizer Inc, NDC labeler code 0071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lyrica?
- 9 other product NDCs are listed under this name. See all Lyrica NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lyrica products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lyricapregabalin | Pregabalin 300 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-242 | 58151-0242-77 |
| Lyricapregabalin | Pregabalin 75 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-238 | 58151-0238-7758151-0238-88 |
| Lyricapregabalin | Pregabalin 200 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-241 | 58151-0241-77 |
| Lyricapregabalin | Pregabalin 225 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-243 | 58151-0243-77 |
| Lyricapregabalin | Pregabalin 25 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-236 | 58151-0236-77 |
| Lyricapregabalin | Pregabalin 50 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-237 | 58151-0237-7758151-0237-88 |
| Lyricapregabalin | Pregabalin 150 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-240 | 58151-0240-7758151-0240-88 |
| Lyricapregabalin | Pregabalin 100 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-239 | 58151-0239-7758151-0239-88 |
| Lyricapregabalin | Pregabalin 20 mg/mL | SolutionOral | Viatris Specialty LLC | 58151-244 | 58151-0244-35 |
Other NDCs under NDA 021446
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lyricapregabalin | Pregabalin 75 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-238 |
| Lyricapregabalin | Pregabalin 25 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-236 |
| Lyricapregabalin | Pregabalin 50 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-237 |
| Lyricapregabalin | Pregabalin 200 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-241 |
| Lyricapregabalin | Pregabalin 100 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-239 |
| Lyricapregabalin | Pregabalin 150 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-240 |
| Lyricapregabalin | Pregabalin 300 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-242 |
| Lyricapregabalin | Pregabalin 225 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-243 |